Articles in Press [7 articles]

• A PROSPECIVE, MULTINATIONAL PHARMACOEPMIOLOGICAL STUDY OF CLINICAL CONVERSION TO SIROLIMUS IMMUNOSUPPRESSION AFTER RENAL TRANSPLANTATION, B. L. Kasiske, B. Nashan, Maria Del Carmen Rial, Pablo Raffaele, Graeme Russ, J. M. Campistol, M. D. Pescovitz, and Paul A. Keown
• THE MAJOR HISTOCOMPATIBILITY COMPLEX IN TRANSPLANTATION, Marco Antonio Ayala García, Beatriz González Yebra, Andrea Liliana López Flores, and Eduardo Guaní Guerra
• Identification of risk factors for vascular thrombosis may reduce early renal graft loss – a review of recent literature, Anna Krarup Keller, Troels Munch Jørgensen, and Bente Jespersen
• Progression from Sustained BK-viruria to Sustained BK-viremia with immunosuppression reduction is not associated with Changes in the Noncoding Control Region of the BK-virus Genome, Imran Memon, Bijal Parikh, Monique Gaudreault-Keener, Rebecca Skelton, G. A. Storch, and Daniel C. Brennan
• CD28 family and chronic rejection: "To belatacept ... and beyond!", Marcos Vinícius Silva, Juliana Reis Machado, Laura Penna Rocha, Lúcio Roberto Castellano, Marlene Antônia dos Reis, and Rosana Rosa Miranda Corrêa
• ARE WE READY FOR THE USE OF FOXP3+ REGULATORY T CELLS (Tregs) FOR IMMUNODIAGNOSIS AND IMMUNOTHERAPY IN KIDNEY TRANSPLANTATION?, Francisco Salcido-Ochoa, Nurhashikin Yusof, Susan Swee Shan Hue, Doreen Haase, Terence Kee, and Olaf Rotzschke
• A Randomized Multicenter Study comparing a Tacrolimus-based Protocol with and without Steroids in HCV Positive Liver Allograft Recipients, Ulf Peter Neumann, Didier Samuel, Pavel Trunecka, Jean Gugenheim, Giorgio Enrico Gerunda, and Styrbjorn Friman